We are live on
!
Find out more
ARTA
A.R.T. Advisors Portfolio holdings
AUM
$1.79M
1-Year Est. Return
57.47%
This Fund
S&P 500
This Quarter
Est. Return
+2.65%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$1.89B
AUM Growth
-$283M
(-13%)
Cap. Flow
-$295M
Cap. Flow
% of AUM
-15.65%
Top 10 Holdings %
Top 10 Hldgs %
7.6%
Holding
2,000
New
609
Increased
340
Reduced
399
Closed
638
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$10.9M |
| 2 |
Macy's
M
|
+$10.7M |
| 3 |
Devon Energy
DVN
|
+$9.78M |
| 4 |
Dollar Tree
DLTR
|
+$9.62M |
| 5 |
JNPR
Juniper Networks
JNPR
|
+$9.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$15.4M |
| 2 |
Micron Technology
MU
|
+$14.7M |
| 3 |
Merck
MRK
|
+$13.1M |
| 4 |
Lam Research
LRCX
|
+$13M |
| 5 |
Capital One
COF
|
+$12.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 13.55% |
| 2 | Technology | 13.54% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Healthcare | 12.74% |
| 5 | Financials | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Geron
GERN
$911M
| $131K | 0.01% |
47,600
-121,500
| -72% | -$323K |
|
1227
NLI Holdings
NL
$284M
| $131K | 0.01% |
+18,720
| New | +$147K |
|
|
PGTI
1228
DELISTED
PGT, Inc.
PGTI
| $130K | 0.01% |
+10,200
| New | +$117K |
|
|
AGEN
1229
Agenus
AGEN
$249M
| $129K | 0.01% |
+1,693
| New | +$119K |
|
|
DSPG
1230
DELISTED
DSP Group Inc
DSPG
| $129K | 0.01% |
+11,136
| New | +$135K |
|
|
SNAK
1231
DELISTED
Inventure Foods, Inc.
SNAK
| $129K | 0.01% |
29,977
-5,900
| -16% | -$24.2K |
|
|
LAYN
1232
DELISTED
Layne Christensen Co
LAYN
| $127K | 0.01% |
14,467
+2,300
| +19% | +$18.7K |
|
|
WLB
1233
DELISTED
Westmoreland Coal Company
WLB
| $125K | 0.01% |
25,804
-70,747
| -73% | -$619K |
|
1234
Gran Tierra Energy
GTE
$260M
| $123K | 0.01% |
5,509
-20,526
| -79% | -$499K |
|
|
PSTB
1235
DELISTED
Park Sterling Corp.
PSTB
| $123K | 0.01% |
10,401
-3,200
| -24% | -$38.1K |
|
|
SIEN
1236
DELISTED
Sientra, Inc.
SIEN
| $121K | 0.01% |
+1,245
| New | +$102K |
|
|
ENZ
1237
DELISTED
Enzo Biochem, Inc.
ENZ
| $116K | 0.01% |
+10,573
| New | +$98.5K |
|
1238
Gevo
GEVO
$397M
| $115K | 0.01% |
8,373
-584
| -7% | -$10K |
|
|
ALIM
1239
DELISTED
Alimera Sciences
ALIM
| $115K | 0.01% |
+5,539
| New | +$119K |
|
|
SMRT
1240
DELISTED
Stein Mart Inc
SMRT
| $115K | 0.01% |
68,422
+11,200
| +20% | +$22.1K |
|
|
EIGR
1241
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $113K | 0.01% |
+478
| New | +$109K |
|
|
HIL
1242
DELISTED
Hill International, Inc. Common Stock
HIL
| $113K | 0.01% |
+21,814
| New | +$99K |
|
1243
Galectin Therapeutics
GALT
$229M
| $112K | 0.01% |
+45,843
| New | +$122K |
|
|
DRD
1244
DRDGold
DRD
$1.82B
| $111K | 0.01% |
35,376
+13,971
| +65% | +$52.6K |
|
1245
LSB Industries
LXU
$881M
| $110K | 0.01% |
+13,894
| New | +$98.7K |
|
|
CBMG
1246
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $110K | 0.01% |
+12,587
| New | +$111K |
|
|
ADAP
1247
DELISTED
Adaptimmune Therapeutics
ADAP
| $108K | 0.01% |
24,108
-9,665
| -29% | -$50.5K |
|
1248
DHI Group
DHX
$166M
| $108K | 0.01% |
38,118
-7,123
| -16% | -$23.4K |
|
|
CBK
1249
DELISTED
Christopher & Banks Corporation
CBK
| $108K | 0.01% |
82,999
+15,096
| +22% | +$19.2K |
|
|
BEBE
1250
DELISTED
Bebe Stores Inc
BEBE
| $105K | 0.01% |
+17,835
| New | +$84.7K |
|
Similar funds
MA
FFIM
LC
YEPV
AAM
CCM
IR
IFC
A.R.T. Advisors's Q2 2017 Portfolio in Review
As of Q2 2017, A.R.T. Advisors held 2,000 positions worth $1.89B, down 13% from $2.17B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.
A.R.T. Advisors withdrew a net $295M in Q2 2017, closing 638 positions and reducing 399 holdings. Its most notable exit was Micron Technology, an estimated $14.7M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 11% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, A.R.T. Advisors opened a new position in Broadcom worth $8.79M.
- A.R.T. Advisors's largest Q2 2017 buy was Broadcom: 377,000 shares worth $8.79M.
- A.R.T. Advisors added most to Amgen in Q2 2017, an estimated $10.9M increase.
- A.R.T. Advisors's biggest Q2 2017 reduction was Amazon, cutting an estimated $15.4M.
- A.R.T. Advisors fully exited Micron Technology in Q2 2017, selling an estimated $14.7M.
- A.R.T. Advisors's ten largest holdings make up 7.6% of its $1.89B portfolio in Q2 2017.
- A.R.T. Advisors opened 609 new positions and closed 638 in Q2 2017.
- A.R.T. Advisors's portfolio value fell 13% quarter-over-quarter to $1.89B.
Based on A.R.T. Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.